Mulmit

ADC Therapeutics SAADC Therapeutics SA

ADCT NYSE

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2023-12-3169,060,000-165,986,000-240,100,000-2.94
2022-12-3174,908,000-123,344,000-157,128,000-2.01

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-06-30Zaki MohamedChief Medical Officer213,900
2026-06-30GRAHAM PETER JChief Legal Officer221,100
2026-06-30Carmona JoseChief Financial Officer203,700
2026-06-30MALLIK AMEETChief Executive Officer675,000
2026-06-03Azelby Robert12,600
2026-06-03Squarer Ron15,196
2026-06-03Sandor Victor12,600
2026-06-03Monges Viviane2,596
2026-06-03Hug Peter2,156
2026-06-03BIZZARI JEAN-PIERRE12,600
2026-06-03Coughlin Timothy12,600
2026-06-01Azelby Robert45,000

8-K events

FiledItems
2026-08-13Results of operations · Regulation FD disclosure · Financial statements and exhibits
2026-07-02Officer or director change
2026-06-24Regulation FD disclosure · Other events · Financial statements and exhibits
2026-06-03Regulation FD disclosure · Other events · Financial statements and exhibits
2026-06-02Submission of matters to a vote · Financial statements and exhibits
2026-05-04Results of operations · Financial statements and exhibits
2026-03-10Results of operations · Financial statements and exhibits
2026-02-23Entry into a material agreement · Unregistered sales of equity securities · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.